(Q53973832)

23 May 2018

title

Mutations associated with genotypic resistance to antiretroviral therapy in treatment naïve HIV-1 infected patients in Greece. (English)

1 reference

23 May 2018

main subject

anti-retroviral agent

0 references

1 reference

2

1 reference

23 May 2018

author name string

Magiorkinis E

1

1 reference

23 May 2018

Magiorkinis G

3

1 reference

23 May 2018

Chryssou S

4

1 reference

23 May 2018

Chini M

5

1 reference

23 May 2018

Lazanas M

6

1 reference

23 May 2018

Paparizos V

7

1 reference

23 May 2018

Saroglou G

8

1 reference

23 May 2018

Antoniadou A

9

1 reference

23 May 2018

Giamarellou E

10

1 reference

23 May 2018

Karafoulidou A

11

1 reference

23 May 2018

Hatzakis A

12

1 reference

23 May 2018

publication date

1 April 2002

1 reference

23 May 2018

published in

Virus Research

1 reference

23 May 2018

volume

85

1 reference

23 May 2018

issue

1

1 reference

23 May 2018

page(s)

109-115

1 reference

23 May 2018

Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug users

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatment-naive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

HIV-1 drug resistance in newly infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Brief report: primary infection with zidovudine-resistant human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Sexual transmission of an HIV-1 variant resistant to multiple reverse-transcriptase and protease inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Reduced antiretroviral drug susceptibility among patients with primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Protease sequences from HIV-1 group M subtypes A-H reveal distinct amino acid mutation patterns associated with protease resistance in protease inhibitor-naive individuals worldwide. HIV Variant Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Prevalence of mutations associated with reduced antiretroviral drug susceptibility among human immunodeficiency virus type 1 seroconverters in the United States, 1993-1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

Transmission of antiretroviral-drug-resistant HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FS0168-1702%2802%2900022-9

7 January 2021

10.1016/S0168-1702(02)00022-9

Identifiers

DOI

1 reference

23 May 2018

PubMed ID

11955643

1 reference

23 May 2018